GSK Plc (GSK)
49.67
-1.29
(-2.53%)
USD |
NYSE |
May 15, 16:00
49.67
0.00 (0.00%)
Pre-Market: 20:00
GSK EPS Diluted (Quarterly) : 1.149 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.9849 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
| Novo Nordisk A/S | 1.709 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.478B |
| Revenue (Quarterly) | 10.28B |
| Total Expenses (Quarterly) | 7.939B |
| Enterprise Value | 119.73B |
| Gross Profit Margin (Quarterly) | 75.45% |
| Profit Margin (Quarterly) | 24.11% |
| Earnings Yield | 7.70% |
| Operating Earnings Yield | 10.04% |
| Normalized Earnings Yield | 8.402 |